Patents by Inventor Akihiro Kasai

Akihiro Kasai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11124135
    Abstract: A pair of floor-side extensions are provided in the vehicle width direction on the lower surface of at least one of a dash lower panel and a floor panel constituting the floor of a vehicle chamber so as to protrude downward in front of the battery unit front surface with a high voltage cable interposed between the pair of floor-side extension members. A pair of member-side extensions are provided so as to protrude upward at positions facing the pair of floor-side extensions in the vehicle front-and-rear direction on the rear end edge of a suspension member.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: September 21, 2021
    Assignee: TOYOTA JIDOSHA KABUSHIKI KAISHA
    Inventors: Akihiro Yamada, Kenshi Tomiki, Yusuke Fujii, Satoshi Kasai
  • Publication number: 20100249413
    Abstract: [Problem] A stable liquid-form pharmaceutical composition wherein the decomposition with time is prevented and a stabilization method thereof is provided, for providing a liquid-form pharmaceutical composition of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazol-3-ium or a pharmaceutically acceptable salt thereof to a clinical field. [Means for Solution] Related are a stable pharmaceutical composition of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazol-3-ium or a pharmaceutically acceptable salt thereof, containing one kind or two or more kinds selected from the group consisting of carbazochrome sodium sulfonate and derivatives thereof, vitamin C's, butylhydroxylanisol, vitamin E's, Vitamin P's, gallic acid, propyl gallate, alpha-thioglycerine and cysteine hydrochloride, as well as a lyophilized product thereof and a stabilizing method thereof.
    Type: Application
    Filed: August 24, 2007
    Publication date: September 30, 2010
    Inventors: Makoto Murai, Yuichi Yonemochi, Kohsuke Shakushiro, Akihiro Kasai
  • Patent number: 7112565
    Abstract: A stabilized pharmaceutical composition in lyophilized form comprising: a cyclic polypeptide compound represented by the general formula (I): wherein R1 is a hydrogen atom or an acyl group and R2 and R3 are, the same or different, a hydrogen atom or a hydroxyl group, or a salt thereof and the stabilizer.
    Type: Grant
    Filed: February 6, 2004
    Date of Patent: September 26, 2006
    Assignee: Astellas Pharma Inc.
    Inventors: Seiji Sawai, Akihiro Kasai, Kazumi Ohtomo
  • Patent number: 7034780
    Abstract: A plasma display device is provided which is capable of preventing image disturbance and imposition of excessive loads even when resolution is switched. A vertical frequency counter counts vertical sync signals using system clocks and a vertical frequency comparator checks whether or not the value obtained from the counting matches up with a vertical frequency decoded value. A line number counter counts vertical sync signals using horizontal sync signals and a line number comparator checks whether or not the value obtained from the counting matches up with a line number decoded value. A dot number counter counts horizontal sync signals using analog digital clocks and a dot number comparator checks whether or not the value obtained from the counting matches up with a dot number decoded value. These values are ORed by an OR circuit and the result is output in a form of a mode monitoring detection signal.
    Type: Grant
    Filed: December 27, 2002
    Date of Patent: April 25, 2006
    Assignee: Pioneer Corporation
    Inventors: Satoshi Fujita, Akihiro Kasai
  • Patent number: 6984397
    Abstract: The present invention provides a pipecolic acid derivative-containing liposome preparation having has an excellent rapid action capable of coping with an emergent situation such as cerebral infarction. A liposome preparation characterized by comprising, as an active ingredient, a pipecolic acid derivative of the ingredient described in the present specification or a pharmaceutically acceptable salt thereof entrapped into liposomes, wherein lecithin is mainly used as the liposome-forming lipid, said liposome preparation containing no cholesterol as a stabilizer.
    Type: Grant
    Filed: August 8, 2003
    Date of Patent: January 10, 2006
    Assignee: Fujisawa Pharmaceutical Company, Ltd.
    Inventors: Jiro Fujisaki, Hajime Konno, Akihiro Kasai, Kazumi Ohtomo
  • Patent number: 6979461
    Abstract: An object of the present invention is to provide a method for producing a liposome preparation having excellent rapid action and excellent redispersion into aqueous medium. The present invention provides a method for producing a liposome preparation by vacuum drying wherein liposome condensed solution, which is obtained by removing solvent from liposome solution, is subjected to vacuum drying without freezing while bubbling the condensed solution or after the condensed solution is bubbled.
    Type: Grant
    Filed: October 3, 2000
    Date of Patent: December 27, 2005
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Kazumi Ohtomo, Hajime Konno, Akihiro Kasai
  • Publication number: 20040157769
    Abstract: A stabilized pharmaceutical composition in lyophilized form comprising:
    Type: Application
    Filed: February 6, 2004
    Publication date: August 12, 2004
    Applicant: Fujisawa Pharmaceutical Co. Ltd.
    Inventors: Seiji Sawai, Akihiro Kasai, Kazumi Ohtomo
  • Patent number: 6774104
    Abstract: A stabilized pharmaceutical composition in lyophilized form comprising: a cyclic polypeptide compound represented by the general formula (I): wherein R1 is a hydrogen atom or an acyl group and R2 and R3 are, the same or different, a hydrogen atom or a hydroxyl group, or a salt thereof and the stabilizer.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: August 10, 2004
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Seiji Sawai, Akihiro Kasai, Kazumi Otomo
  • Publication number: 20040028728
    Abstract: The present invention provides a pipecolic acid derivative-containing liposome preparation having has an excellent rapid action capable of coping with an emergent situation such as cerebral infarction.
    Type: Application
    Filed: August 8, 2003
    Publication date: February 12, 2004
    Applicant: Fujisawa Pharmaceutical Company, Ltd.
    Inventors: Jiro Fujisaki, Hajime Konno, Akihiro Kasai, Kazumi Ohtomo
  • Publication number: 20030122744
    Abstract: A plasma display device is provided which is capable of preventing image disturbance and imposition of excessive loads even when resolution is switched. A vertical frequency counter counts vertical sync signals using system clocks and a vertical frequency comparator checks whether or not the value obtained from the counting matches up with a vertical frequency decoded value. A line number counter counts vertical sync signals using horizontal sync signals and a line number comparator checks whether or not the value obtained from the counting matches up with a line number decoded value. A dot number counter counts horizontal sync signals using analog digital clocks and a dot number comparator checks whether or not the value obtained from the counting matches up with a dot number decoded value. These values are ORed by an OR circuit and the result is output in a form of a mode monitoring detection signal.
    Type: Application
    Filed: December 27, 2002
    Publication date: July 3, 2003
    Applicant: NEC PLASMA DISPLAY CORPORATION
    Inventors: Satoshi Fujita, Akihiro Kasai
  • Patent number: 5905282
    Abstract: A multi-terminal surge protection device able to absorb surges of either polarity between lines and between a line and ground, in which the difference in operating time between the device elements connected to lines is reduced. A plurality of unipolar surge protection device elements are used which only operate to absorb surges of a specific polarity, and do not exhibit a reverse withstand characteristic upon application of a reverse-polarity voltage. One element is connected to a first line and another element to a second line, while a different element is connected to ground. A semiconductor substrate and second electrode are used that are common to all elements. To prevent lateral interference between elements, at least the element connected to ground is isolated from the line elements.
    Type: Grant
    Filed: May 15, 1997
    Date of Patent: May 18, 1999
    Assignees: Sankosha Corporation, Optotechno Co., Ltd.
    Inventors: Masaaki Sato, Mitsuru Inoue, Yasuharu Yamada, Akihiro Kasai, Hideyuki Harada, Hirofumi Yoshihara